Clinical Implications of CNS Penetration of Antiretroviral Drugs
- 1 January 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in CNS Drugs
- Vol. 16 (9), 595-609
- https://doi.org/10.2165/00023210-200216090-00002
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- In Vivo Effect of α 1 -Acid Glycoprotein on Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Protease InhibitorAntimicrobial Agents and Chemotherapy, 2001
- Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase InhibitorsClinical Pharmacokinetics, 2001
- Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudineThe Lancet, 1998
- Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brainAnnals of Neurology, 1997
- Study on didanosine concentrations in cerebrospinal fluidInternational Journal of Clinical Pharmacy, 1995
- Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II StudyThe Journal of Infectious Diseases, 1995
- Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agentsInternational Journal of Clinical Pharmacy, 1995
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- Pharmacokinetics of 2‘,3’-Dideoxycytidine in Patients with AIDS and Related DisordersThe Journal of Clinical Pharmacology, 1988
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987